Tag: mortality risks

FDA issues Class I alert for Abiomed Impella heart device over cybersecurity risks

Editor's Note The Food and Drug Administration (FDA) on October 10 classified a cybersecurity correction involving Abiomed’s Automated Impella Controller as a Class I recall, the most serious type, according to the FDA Medical Device Recalls and Early Alerts database. While devices are not being removed from clinical settings, the…

Read More

By: Tarsilla Moura
October 10, 2025
Share

Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI

Editor's Note Older adults with a body mass index (BMI) in the overweight range had significantly lower odds of death after major elective surgery compared with those in the normal BMI category, an August 26 study published by JAMA Network reports. The cohort study followed 414 adults aged 65 years…

Read More

By: Tarsilla Moura
September 30, 2025
Share

FDA posts four device safety communications, prompting inventory, workflow checks

Editor's Note The Food and Drug Administration (FDA) has issued four medical device recalls and early alerts between September 23 and 30, covering Automated Impella Controllers, Olympus ViziShot 2 FLEX (19G) endoscopic aspiration needles, 3M Ranger blood and irrigation fluid warming systems, and BD Alaris infusion pump sets. The notices…

Read More

By: Tarsilla Moura
September 30, 2025
Share

Nutrition screening tool predicts poor outcomes after pancreatic cancer surgery

Editor's Note The Perioperative Nutrition Screen (PONS) identifies patients at greater risk of complications following pancreatic cancer surgery, according to a retrospective analysis published August 27 by Research Square. The study found that patients flagged for nutrition risk by PONS experienced longer hospital stays, higher complication rates, and were more…

Read More

By: Tarsilla Moura
September 29, 2025
Share

Fall deaths among older adults have tripled, prescription drugs under scrutiny

Editor's Note Deaths from falls among Americans over 65 have more than tripled in the past 3 decades, raising alarm among geriatric experts and fueling debate about the role of prescription drugs, HealthLeaders September 15 reports. The Centers for Disease Control and Prevention (CDC) recorded more than 41,000 fall-related deaths…

Read More

By: Tarsilla Moura
September 18, 2025
Share

Study identifies risk factors for PE and DVT after ambulatory surgery

Editor's Note Pulmonary embolism (PE) and deep vein thrombosis (DVT) are rare after same-day surgeries, but when they occur, they carry high risks of death and readmission. According to Anesthesiology News May 12, a University of Texas Southwestern Medical Center analysis of more than 1.1 million outpatient procedures found an…

Read More

By: Tarsilla Moura
September 16, 2025
Share

Endoscopy case highlights risks of complex patients in ASCs

Editor's Note A malpractice case involving a 69-year-old man undergoing an endoscopy at an ambulatory surgery center (ASC) spotlights the risks of managing high-comorbidity patients outside a hospital setting. According to a May 13 report in Anesthesiology News, the patient experienced a hypoxic event that led to permanent brain injury…

Read More

By: Tarsilla Moura
September 2, 2025
Share

FDA issues Class I recall for Philips BiPAP ventilators

Editor's Note Philips Respironics BiPAP A30, A40, and V30 Auto ventilators are subject to a Class 1 recall—the US Food and Drug Administration’s (FDA’s) most severe category indicating risk of serious injury or death—due to the risk for a failure in the Ventilator Inoperative alarm, which can cause therapy interruption…

Read More

By: Matt Danford
August 5, 2025
Share

FDA designates Class I recall for disposable surgical stapler cartridge correction

Editor's Note The US Food and Drug Administration (FDA) has designated the recall of Ethicon Endo-Surgery, LLC’s Endopath Echelon Vascular White Reload for Advanced Placement Tip a Class I, the most severe category indicating risk of serious injury or death. As detailed in the agency’s July 25 announcement,  the recall…

Read More

By: Matt Danford
July 28, 2025
Share

FDA designates Class I recall for mobile lift component

Editor's Note The US Food and Drug Administration (FDA) has designated Baxter’s recall of the Q-Link 13 mobile lift component a Class I, the most severe category indicating risk of serious injury or death. As detailed in the agency’s July 23 announcement, the optional component connects to sling bars on…

Read More

By: Matt Danford
July 24, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat